Sen. Rev. Raphael Warnock of Georgia has challenged the nation's largest payers to follow in the footsteps of UnitedHealthcare and reduce or eliminate out-of-pocket costs for insulin.
Mr. Warnock sent letters to Elevance Health, Centene, Cigna, CVS Health, Humana, Kaiser Permanente and Molina Healthcare, according to a July 25 news release.
On July 15, UnitedHealthcare said it will cover the cost of insulin, epinephrine, glucagon, naloxone and albuterol for members starting in January, pending regulatory approval.
"The high cost of insulin is an issue that touches far too many Georgians and Americans," Mr. Warnock wrote. "…Patients who already have health insurance, and pay health insurance premiums, should be able to afford their insulin."